Continuous glucose monitoring is transforming diabetes care with real-time CGM data that goes beyond A1C. Clinicians use time in range, ambulatory glucose profile, and glucose trends to personalize tr ...
Biotech stocks remain attractive in 2026 as companies with strong drug portfolios, regulatory approvals, and solid cash flow outperform speculative names. Vertex, Gilead, Regeneron, Argenx, and CRISPR ...
Donald Trump’s phased tariff plan on imported generic drugs gives companies two years before steep duties begin, raising concerns for India’s pharmaceutical exporters, supply chains, and the future of ...
.png){kind=logo}
